TAK Takeda Pharmaceutical
- 13.390
- +0.020+0.15%
Takeda Pharmaceutical News
Takeda Pharmaceutical | 6-K: Quarterly Securities Report For The Nine-month Period and Three-month Quarter Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Summary of Financial Statements for the Nine-month Period Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Partial Amendment to Corporate Governance Report
Takeda Pharmaceutical | 6-K: The 147th (interim period) Business Report
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 20-F: FY2023 Annual Report
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
